December 23, 2006
Eli Lilly Responses to NYT Articles on Zyprexa Misconduct
Point of Law notes that Eli Lilly has responded to the New York Times articles discussing Zyprexa misconduct. Here are links to Eli Lilly's response to the 12/17 NYT article, Eli Lilly's response to the 12/18 NYT article, and Eli Lilly's response to the 12/21 NYT article.
TrackBack URL for this entry:
Listed below are links to weblogs that reference Eli Lilly Responses to NYT Articles on Zyprexa Misconduct:
Eli Lilly makes billions on diabetes treatment and also gets $4.2 billion a year in sales of their biggest cash cow Zyprexa which has been scandalized as *causing* diabetes as a major side effect.
Not fair~Daniel Haszard
Posted by: Daniel Haszard | Jan 1, 2007 1:19:32 PM